Error: Could not add to watchlist. X

Biogen Inc

+ Watchlist
BIIB:US
NASDAQ GS
314.10
USD
0.76
0.24%
As of 09:53:21 ET on 07/30/2015.
Open
312.54
Day Range
310.52 - 315.49
Volume
310,564
Previous Close
313.34
52Wk Range
290.85 - 480.18
1 Yr Return
-8.79%
Open
312.54
Day Range
310.52 - 315.49
Volume
310,564
Previous Close
313.34
52Wk Range
290.85 - 480.18
1 Yr Return
-8.79%
YTD Return
-7.43%
Current P/E Ratio (TTM)
21.36
Earnings per Share (USD) (TTM)
14.67
Market Cap (b USD)
73.688
Shares Outstanding (m)
235.169
Price/Sales (TTM)
7.18
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

Profile
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
ADDRESS
225 Binney Street
Cambridge, MA 02142
United States
PHONE
781-464-2000
  • George A Scangos
    Chief Executive Officer
  • Susan H Alexander
    Exec VP/Chief Legal Ofcr/Secy
  • Paul J Clancy
    Exec VP:Finance/CFO
  • Stephen H Holtzman "Steve"
    Exec VP:Corporate Development
  • Stuart A Kingsley "Tony"
    Exec VP:Global Commercial Ops
Show More